Dr. Rajaram Anantharaman is an accomplished cardiologist and clinician-researcher with extensive international clinical, academic, and research experience. He demonstrated exceptional academic performance from the outset, completing his MBBS with Overall First Class, with Honours in Anatomy and Physiology, and distinctions in all subjects in his Higher Secondary Examination. He was also a National Merit Scholarship Holder in Tamil Nadu.

His professional training includes extensive experience in the United Kingdom, encompassing General Medicine, Geriatric Medicine, Haematology, Respiratory Medicine, Diabetes and Endocrinology, and Cardiology. He subsequently completed a 16-month Interventional Cardiology Fellowship under the All Wales Training Programme at Morriston Hospital, Swansea.

Clinical & Professional Experience

Dr. Anantharaman has developed broad expertise in internal medicine and advanced cardiovascular care through appointments in India and the UK. His early clinical training at Stanley Medical College, Madras, provided experience across General Medicine, General Surgery, Obstetrics and Gynaecology, Orthopaedics, Paediatrics, and Community Medicine.

In the UK, he managed a wide range of acute and chronic medical conditions and gained experience in medical emergencies, diabetes and endocrine disorders, respiratory medicine, geriatric medicine, haematology, and cardiology. His interventional cardiology training further strengthened his expertise in invasive cardiovascular procedures and contemporary coronary intervention.

Research & Scientific Contributions

Dr. Anantharaman's research career has focused particularly on interventional cardiology, percutaneous coronary intervention (PCI), antiplatelet therapy, platelet biology, and pharmacogenetics. His MD research examined the safety and feasibility of day-case radial-access PCI and approaches to optimizing antiplatelet treatment in elective PCI.

His research portfolio included the RADICAL Study, investigating day-case PCI through radial access; the ENFORCED Study, evaluating shortened abciximab infusion and platelet response; and the PROTECTED Study, examining high-dose clopidogrel, platelet activation, and P2Y12 receptor polymorphisms. His research also explored mechanisms of antiplatelet non-response and the potential for personalized optimization of treatment.

Pioneering Clinical Innovations & First-in-India Achievements

Dr. Anantharaman has been at the forefront of several landmark cardiovascular innovations in India, contributing to the introduction and successful execution of multiple pioneering structural heart, heart failure, and transcatheter valve interventions. His work has played a significant role in advancing complex cardiovascular therapies and expanding treatment options for high-risk patients.

Advanced Heart Failure & Heart Transplantation

His contributions to advanced heart failure management and transplant cardiology include participation and leadership in several nationally pioneering procedures:

• India's first Mechanical Circulatory Support (MCS) bridge (VA-ECMO + IABP) to redo heart transplantation (2017) as Lead Cardiologist.
• India's first MCS bridge utilizing Impella, IABP, and VA-ECMO to adult heart transplantation for cardiogenic shock (2022) as Lead Cardiologist.
• India's first MitraClip/Carillon device bridge to heart transplantation (2016), contributing to innovative pathways for advanced heart failure management.

Hypertrophic Cardiomyopathy & Preventive Cardiology

• Established and launched India's first Cardiac Risk in the Young (CRY) Clinic in 2015, dedicated to the identification and prevention of inherited and sudden cardiac death-related cardiovascular disorders among young individuals.

Transcatheter Heart Valve (THV) & Structural Heart Interventions

Dr. Anantharaman has been associated with numerous pioneering transcatheter valve therapies and structural heart interventions, including:

• India's first Valve-in-Valve Transcatheter Aortic Valve Implantation (TAVI) (2015).
• First Transcatheter Pulmonary Valve Implantation in South India (2019).
• India's first combined Trans-Caval TAVR, TEVAR, and PCI procedure (2020).
• India's first BASILICA-assisted TAVR procedure (2021).
• India's first TAVR performed with Micra Transcatheter Pacing System (TPS) (2022).
• India's first Double Valve-in-Valve (Aortic and Mitral) Transcatheter Heart Valve procedure with Micra TPS (2022).
• India's first Tip-to-Base LAMPOON with IABP-assisted Valve-in-Valve Transcatheter Mitral Valve Replacement (TMVR) (2023).
• India's first Python XL Balloon Dilatation multi-wire port sheath-assisted TAVR (2024).

First-in-Man & Novel Structural Heart Innovations

His involvement in cutting-edge cardiovascular innovation includes:

• First-in-Man proof-of-concept Transcatheter Transvenous Transseptal Mitral Valve implantation in severe Mitral Annular Calcification (MAC) utilizing an extended external wrap and atrialized implantation strategy.
• India's first laser-assisted primary angioplasty procedure.
• India's first Intracardiac Echocardiography (ICE)-guided Left Atrial Appendage Occlusion (LAAO) procedure.

Publications & Research Recognition

Dr. Anantharaman has contributed to 23 publications and has been involved in several multicentre drug and device trials. His research on elective PCI and antiplatelet therapy received external recognition through the North-West Region R&D Bursary Award, UK (2004), valued at £10,000.

His research was also published in the Heart journal, reflecting the clinical relevance and scientific value of his work in interventional cardiology.

Awards & Honours

His distinguished career has been supported by several competitive awards and academic recognitions, including:

• Best Paper Award, 6th Annual Meeting AFHFTCN, Coimbatore, 2018
• Best Case Award for Valve-in-Valve TAVI, CSI Midterm Meet, Hyderabad, 2018
• Best Clinical Case Award, Advanced Clinical Education Programme, Malaga, 2009
• Finalist, BJCA-Cordis International Fellowship Award, 2005
• North-West Region R&D Bursary Award, UK, 2004
• National Merit Scholarship, Tamil Nadu
• MBBS Overall First Class, with Honours in Anatomy and Physiology

Professional Accolades

Advanced Heart Failure and Heart Transplant

• India’s 1st MCS bridge (VA ECMO + IABP) to Re-do Heart Transplant in Sep 2017 as Lead Cardiologist (FLL Team)
• India’s 1st MCS bridge (Impella+ IABP+VA ECMO) to Adult Heart Transplant for CS in 2022 as Lead Cardiologist (Kauvery Team)
• India’s first Mitraclip / Carillion device bridge to Heart Transplant in 2016 (FLL Team) Hypertrophic Cardiomyopathy
• Launched the first Cardiac Risk in Young C R Y clinic in India in 2015

THV (Trans-catheter Heart Valve ) Therapy

• India’s 1st case of Valve in Valve TAVI in 2015 - First case of Trans-catheter Pulmonary Valve Implantation in South India in2019
• India’s 1st Trans-Caval TAVR+ TEVAR+ PCI 2020 (Heart Team India)
• India’s 1st BASILICA assisted TAVR 2021 (Heart Team India)
• India’s 1st TAVR with Micra TPS 2022 
• India’s 1st Double Valve in valve (Aortic/Mitral) THV with Micra TPS 2022
• India’s 1st Tip to Base LAMPOON + IABP assisted ViV TMVR 2023
• India’s 1st Python XL BD multi-wire port sheath assisted TAVR 2024

FIM Proof of concept: Transcatheter Transvenous Trans-septal Mitral Valve in MAC with Extended external wrap and Atrialized implant 

• India’s first Laser assisted Primary angioplasty
• India’s first Intracardiac Echo (ICE) guided LAAO

Teaching & Academic Contributions

Dr. Anantharaman has demonstrated substantial commitment to medical education through bedside teaching, case-based learning, problem-based teaching, clinical skills training, and formal presentations. His teaching experience encompasses undergraduate medical students, nursing students, paramedical professionals, and postgraduate trainees.

He has contributed to MRCP teaching and clinical courses, Basic Life Support training, cardiology clinical-skills education, and ECG-based academic programmes, reflecting his commitment to developing clinical competence among healthcare professionals.

Areas of Expertise & Research Interest

His principal areas of expertise and research include:

• Interventional cardiology
• Percutaneous coronary intervention
• Radial-access PCI
• Antiplatelet therapy
• Platelet activation and aggregation
• Pharmacogenetics and platelet receptor polymorphisms
• Drug-eluting stents
• Transcatheter aortic valve implantation (TAVI)
• Cardiovascular clinical trials
• Drug and device research
• Personalized cardiovascular therapeutics

Eligibility for Outstanding Researcher Award 

Dr. Rajaram Anantharaman is eligible for the Outstanding Researcher Award in Scientific Laurels based on his distinguished contributions to interventional cardiology, structural heart disease, advanced heart failure, heart transplantation, cardiovascular innovation, and clinical research. In addition to his 23 publications, multicentre clinical trial participation, award-winning research on PCI and antiplatelet therapy, and publication in the journal Heart, his leadership in numerous First-in-India and First-in-Man cardiovascular procedures demonstrates exceptional clinical innovation and translational impact.

His pioneering work in transcatheter valve therapies, mechanical circulatory support, heart transplantation, structural heart interventions, pharmacogenetics, and personalized cardiovascular medicine has contributed significantly to advancing contemporary cardiovascular care in India. Combined with his international training, research productivity, scientific recognition, and commitment to medical education, he represents an outstanding candidate for the Outstanding Researcher Award in Scientific Laurels.